Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests creating a validated score to diagnose Cushing's Syndrome and considers plasma steroid profiling as a simpler diagnostic method.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Dermatoscopy and videodermatoscopy are useful and reliable for tracking treatment progress in various skin conditions.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

The document concludes that computational methods using networks and various data can improve the process of finding new uses for existing drugs.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Early detection and stopping the drug are key to managing DRESS, and careful monitoring is important due to possible severe reactions.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

Dutasteride helps slow hair loss and boosts hair growth.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Scalp cooling is largely ineffective in preventing hair loss from breast cancer chemotherapy.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

Accurate clinical, histological, and genetic methods are key for understanding and treating hair disorders.

Lygodii Spora extract may help treat hair loss by blocking a hair loss-related enzyme and promoting hair growth.

Bergamot may improve heart health, skin conditions, and mood, but more research is needed to confirm these benefits.

Leflunomide and methotrexate are equally effective for rheumatoid arthritis but have different side effects.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Loss of sebaceous glands and inflammation may contribute to the development of scarring alopecia.

A woman's liver was damaged by taking the herbal supplement Shou-Wu-Pian, but it got better after she stopped using it.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

About 3% of high school girls aged 14-18 in Isfahan, Iran, have polycystic ovary syndrome.

Finasteride doesn't reduce sexual function in people with hair loss.

Low-dose flutamide helps reduce excessive hair growth and is even more effective with birth control, without bad effects on blood fats.

Fibromodulin treatment helps reduce scarring and improves wound healing by making it more like fetal healing.

Women with PCOS tend to have higher anxiety and depression levels compared to healthy women.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.